Company intelligence / Profile preview
IOZK
- Ownership
- Private
- Development stage
- Commercial
Overview
IOZK offers individualized immunotherapies for cancer patients, primarily combining autologous dendritic cell vaccines with Newcastle Disease Virus vaccine. They have also begun incorporating immune checkpoint inhibitors into their regimens. Their approach is designed to activate the patient’s own immune system against tumor cells, aiming to improve quality of life and potentially influence disease course positively. Complete cures are rare for advanced tumors, but the therapies may provide benefit in disease control and symptom management[1][2].
- Therapeutic areas
- Oncology
- Modalities
- Dendritic cell therapyOncolytic virus therapy (Newcastle Disease Virus vaccine)Immune checkpoint inhibitor therapy (incorporated into protocols)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on IOZK.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IOZK.